Laurence R. McCarthy
Larry, who joined as an Operating Partner in 2007, serves as Executive Chairman of Bako Diagnostics and of ALPCO Diagnostics. He also serves on the Boards of Nexelis and Protagen and is a Board Observer for GenDx and Interpace Diagnostics. Previously, Larry was served as Chairman, CEO and Chief Technology Officer of Focus Diagnostics, where he built Focus from a $2 million business to a leading esoteric lab with over $80 million in revenues before its acquisition by Quest Diagnostics in 2006. Prior to Focus, Larry held senior positions at Boehringer Mannheim Diagnostics and Becton Dickinson. He holds a Ph.D. in Microbiology from the University of New Hampshire and has served on the faculties of Cornell Medical College, the University of North Carolina School of Medicine and the Johns Hopkins School of Medicine.